AVN Market to Reach $1.1B by 2033 at 6% CAGR
According to FutureWise analysis the market for avascular necrosis in 2023 is US$ 0.53 billion, and is expected to reach US$ 0.9 billion by 2031 at a CAGR of 6.72%. The Avascular Necrosis (AVN) market is on an exciting upward trajectory, currently valued at approximately USD 0.53 billion in 2023 and expected to soar to around USD 0.9 billion by 2031. This remarkable growth, driven by a...
0 التعليقات 0 المشاركات 264 مشاهدة 0 معاينة